Eli Lilly ١ مايو ٢٠٢٦ Eli Lilly boss reports progress in India after Novo's patent expiration - medwatch.com
Eli Lilly ٣٠ أبريل ٢٠٢٦ Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket - Barron's
Eli Lilly ٣٠ أبريل ٢٠٢٦ Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch - BioPharma Dive
Eli Lilly ٣٠ أبريل ٢٠٢٦ Eli Lilly: Stellar Q1 Earnings Put Pharma In Class Of Its Own, It's Ok To Buy Today (LLY) - Seeking Alpha
Eli Lilly ٣٠ أبريل ٢٠٢٦ Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's - Fierce Pharma
Eli Lilly ٢٨ أبريل ٢٠٢٦ Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ - BioSpace
Eli Lilly ٢٨ أبريل ٢٠٢٦ Lilly pens $2.2B pact with Bezos-backed Profluent to work on recombinase-based gene editing - Fierce Biotech
Eli Lilly ٢٨ أبريل ٢٠٢٦ Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
Eli Lilly ٢٧ أبريل ٢٠٢٦ Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs - CNBC
Eli Lilly ٢٧ أبريل ٢٠٢٦ Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion in blood cancer bet - Reuters
Eli Lilly ٢٧ أبريل ٢٠٢٦ Lilly pens $2.3B deal for next-gen JAK inhibitor biotech Ajax - Fierce Biotech
FierceBiotech ٢٤ أبريل ٢٠٢٦ After Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?
BioPharma Dive ٢٤ أبريل ٢٠٢٦ Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
Eli Lilly ٢٤ أبريل ٢٠٢٦ A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B - statnews.com